Recent Updates
Recently added Catalysts
ICAD

iCAD to Report First Quarter 2022 Financial Results on Wednesday, May 11

Key Takeaway: NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2022, after the

Full Press Release Details

NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on Wednesday, May 11.
Wednesday, May 11th at 4:30 PM ET
Domestic: 888-506-0062
International: 973-528-0011
Conference ID: 728427
Webcast: https://www.webcaster4.com/Webcast/Page/2879/45416
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
iCAD Investor Relations
Last updated: Apr 27, 2022